(Q36764780)

16 August 2017

1 reference

title

Methadone death, dosage and torsade de pointes: risk-benefit policy implications (English)

1 reference

16 August 2017

Mark Latowsky

1

1 reference

16 August 2017

publication date

1 December 2006

1 reference

Journal of Psychoactive Drugs

16 August 2017

published in

1 reference

16 August 2017

volume

38

1 reference

16 August 2017

issue

4

1 reference

16 August 2017

page(s)

513-519

1 reference

Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction

16 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2006.10400590

Overdose deaths attributed to methadone and heroin in New York City, 1990-1998.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2006.10400590

An increase in overdose mortality during the first 2 weeks after entering or re-entering methadone treatment in Amsterdam.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2006.10400590

Deaths in the first two weeks of maintenance treatment in NSW in 1994: identifying cases of iatrogenic methadone toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2006.10400590

Fatal methadone toxicity: signs and circumstances, and the role of benzodiazepines

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2006.10400590

Risk factors for overdose mortality: a case-control study within a cohort of intravenous drug users.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2006.10400590

Organising evidence on QT prolongation and occurrence of Torsades de Pointes with non-antiarrhythmic drugs: a call for consensus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2006.10400590

Heroin Addiction—A Metabolic Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2006.10400590

Methadone Treatment of Randomly Selected Criminal Addicts

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2006.10400590

The relationship between mood state and plasma methadone concentration in maintenance patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2006.10400590

Steady-state pharmacokinetics of (R)- and (S)-methadone in methadone maintenance patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2006.10400590

Qt prolongation and Torsades de Pointes in patients infected with human immunodeficiency virus and treated with methadone

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2006.10400590

Psychotropic drugs and the ECG: focus on the QTc interval

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2006.10400590

Methadone and its role in drug-related fatalities in Cologne 1989-2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2006.10400590

Mortality in heroin addiction: impact of methadone treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2006.10400590

The Swedish methadone maintenance program: A controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2006.10400590

Client initiative, inertia, and demographics: more powerful than treatment interventions in methadone maintenance?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2006.10400590

Self-regulation of dose in methadone maintenance with contingent privileges

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2006.10400590

The potential for QT prolongation and pro-arrhythmia by non-anti-arrhythmic drugs: clinical and regulatory implications. Report on a Policy Conference of the European Society of Cardiology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2006.10400590

Contingency management in methadone maintenance: effects of reinforcing and aversive consequences on illicit polydrug use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2006.10400590

QTc interval prolongation associated with intravenous methadone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2006.10400590

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2006.10400590

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2006.10400590

Torsade de pointes associated with very-high-dose methadone

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2006.10400590

Contingency contracting with polydrug-abusing methadone patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2006.10400590

Relationship between prescribing and risk of opiate overdose among drug users in and out of maintenance treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2006.10400590

The impact of methadone induction on cardiac conduction in opiate users

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2006.10400590

Optimizing long-term response to methadone maintenance treatment: a 152-week follow-up using higher-dose methadone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2006.10400590

Long-term Follow-up of Clients of High- and Low-Dose Methadone Programs

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2006.10400590

Fatal methadone and heroin overdoses: time trends in England and Wales

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2006.10400590

Double-blind comparison of methadone and placebo maintenance treatments of narcotic addicts in Hong Kong

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2006.10400590

Prohibition of take-home dosages: negative consequences on methadone maintenance treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2006.10400590

Lethal methadone intoxications in Geneva, Switzerland, from 1994 to 1998.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2006.10400590

Viral hepatitis and drugs: a continuing problem

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2006.10400590

QT interval prolongation in patients on methadone with concomitant drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2006.10400590

A critical review of the causes of death among post-mortem toxicological investigations: analysis of 34 buprenorphine-associated and 35 methadone-associated deaths

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2006.10400590

Problems of methadone diversion and implications for control

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2006.10400590

Risk factors for human immunodeficiency virus infection in intravenous drug users

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2006.10400590

Contingent reinforcement for benzodiazepine-free urines: evaluation of a drug abuse treatment intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2006.10400590

Methadone maintenance treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2006.10400590

The role of methadone in drug-related deaths in the west of Scotland.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2006.10400590

Moderate- vs high-dose methadone in the treatment of opioid dependence: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2006.10400590

Dose-response effects of methadone in the treatment of opioid dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2006.10400590

Tricyclic antidepressants, QT interval prolongation, and torsade de pointes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2006.10400590

Death attributed to methadone

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2006.10400590

Deaths in methadone maintenance treatment in New South Wales, Australia 1990-1995.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2006.10400590

Plasma concentrations of the enantiomers of methadone and therapeutic response in methadone maintenance treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2006.10400590

High Interindividual Variability of Methadone Enantiomer Blood Levels to Dose Ratios

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2006.10400590

Replacement of (R)-methadone by a double dose of (R, S)-methadone in addicts: interindividual variability of the (R)/(S) ratios and evidence of adaptive changes in methadone pharmacokinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2006.10400590

10.1080/02791072.2006.10400590

21 January 2018

Identifiers

DOI

1 reference

16 August 2017

1 reference